Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atorvastatin and Fish Oil for Atrial Fibrillation Prevention After Lung Resection
NCT01259284Phase 3Terminated
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Jan 2011
- Primary completion
- Sep 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of atorvastatin, fish oil concentrate in Atrial fibrillation (AFib), sponsored by University of Texas MD Anderson Cancer Center. Started Jan 2011; status: terminated.
02
Drugs
atorvastatinfish oil concentrate
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT01259284.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01259284.